Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer
Silvia Paola Corona,1 Daniele Generali2 1Radiation Oncology Department, Peter MacCallum Cancer Centre, Bentleigh East, VIC, Australia; 2Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy Abstract: Although early breast cancer (BC) is highly curable, advanced...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018-02-01
|
| coleção: | Drug Design, Development and Therapy |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/abemaciclib-a-cdk46-inhibitor-for-the-treatment-of-hrher2-advanced-bre-peer-reviewed-article-DDDT |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|